Plus Therapeutics (PSTV) Goodwill (2010 - 2026)

Plus Therapeutics (PSTV) reported Goodwill of $372000.0 for Q1 2026, little changed year-over-year from $372000.0 in Q1 2025, and little changed quarter-over-quarter from $372000.0 in Q4 2025.

Plus Therapeutics (PSTV) Goodwill (2010 - 2026) Analysis & Trends

Plus Therapeutics (PSTV) has 17 years of Goodwill data on file, last reported at $372000.0 in Q1 2026.

  • Goodwill for Q1 2026 came in at $372000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $372000.0 (changed 0.0% YoY), and the FY2025 annual result was $372000.0, changed 0.0% from the prior year.
  • Goodwill steadied at $372000.0 in Q1 2026 per PSTV's latest filing, from $372000.0 in the prior quarter.
  • Over five years, Goodwill peaked at $372000.0 in Q1 2022 and troughed at $372000.0 in Q1 2022.
  • A 5-year average of $372000.0 and a median of $372000.0 in 2022 frame the typical range for Goodwill.
  • On a YoY basis, Goodwill climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
  • A 5-year view of Goodwill shows it stood at $372000.0 in 2022, then changed by 0.0% to $372000.0 in 2023, then changed by 0.0% to $372000.0 in 2024, then changed by 0.0% to $372000.0 in 2025, then changed by 0.0% to $372000.0 in 2026.
  • Business Quant data shows PSTV's Goodwill at $372000.0 in Q1 2026, $372000.0 in Q4 2025, and $372000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Plus Therapeutics 37.48 Mn 22.37 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 372,000.00
Dec 31, 2025 372,000.00
Sep 30, 2025 372,000.00
Jun 30, 2025 372,000.00
Mar 31, 2025 372,000.00
Dec 31, 2024 372,000.00
Sep 30, 2024 372,000.00
Jun 30, 2024 372,000.00
Mar 31, 2024 372,000.00
Dec 31, 2023 372,000.00
Sep 30, 2023 372,000.00
Jun 30, 2023 372,000.00
Mar 31, 2023 372,000.00
Dec 31, 2022 372,000.00
Sep 30, 2022 372,000.00
Jun 30, 2022 372,000.00
Mar 31, 2022 372,000.00
Dec 31, 2021 372,000.00
Sep 30, 2021 372,000.00
Jun 30, 2021 372,000.00